Oncology Institute Inc - Asset Resilience Ratio
Oncology Institute Inc (TOI) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Oncology Institute Inc to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Oncology Institute Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Oncology Institute Inc's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Oncology Institute Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Oncology Institute Inc to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Oncology Institute Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Oncology Institute Inc Industry Peers by Asset Resilience Ratio
Compare Oncology Institute Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ramsay Health Care Ltd
AU:RHC |
Medical Care Facilities | 3.49% |
|
Surgery Partners Inc
NASDAQ:SGRY |
Medical Care Facilities | 0.06% |
|
Chularat Hospital Public Company Limited
BK:CHG |
Medical Care Facilities | 1.18% |
|
Sarana Meditama Metropolitan
JK:SAME |
Medical Care Facilities | 0.00% |
|
Principal Capital Public Company Limited
BK:PRINC |
Medical Care Facilities | 1.23% |
|
Bait Bakfar Ltd
TA:BKFR |
Medical Care Facilities | 8.67% |
|
Regis Healthcare Ltd
AU:REG |
Medical Care Facilities | 2.29% |
|
Oceania Healthcare Ltd
AU:OCA |
Medical Care Facilities | 0.01% |
Annual Asset Resilience Ratio for Oncology Institute Inc (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Oncology Institute Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | $0.00 | $172.72 Million | -- |
| 2023-12-31 | 23.59% | $49.37 Million | $209.24 Million | +0.74pp |
| 2022-12-31 | 22.85% | $59.80 Million | $261.67 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $203.44 Million | -- |
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as edu… Read more